Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDIV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Tumor-Agnostic 3Head & Neck 3Gynecologic 3Other neoplasm 1

Conditions

Neoplasms 3

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Proflavine × Tumor-Agnostic × Clear all
NCT06435286 2026-03-02

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

Baylor College of Medicine

Phase 2 Recruiting
200 enrolled
Tumor-Agnostic

Neoplasms

NCT05396781 2022-06-09

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening

Anandasabapathy, Sharmila, M.D.

Phase 2 Completed
41 enrolled
Tumor-Agnostic

Neoplasms

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Anandasabapathy, Sharmila, M.D.

Phase 2 Unknown
1,300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡